Cargando…

The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type

AIM: Bromodomain and extra-terminal domain (BET) proteins are epigenetic readers that play a fundamental role in transcription regulation. Preclinical and early clinical evidence sustain BET targeting as an anti-cancer approach. BET degraders are chimeric compounds comprising of a BET inhibitor, whi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarantelli, Chiara, Cannas, Eleonora, Ekeh, Hillarie, Moscatello, Carmelo, Gaudio, Eugenio, Cascione, Luciano, Napoli, Sara, Rech, Cesare, Testa, Andrea, Maniaci, Chiara, Rinaldi, Andrea, Zucca, Emanuele, Stathis, Anastasios, Ciulli, Alessio, Bertoni, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Open Exploration 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400774/ https://www.ncbi.nlm.nih.gov/pubmed/36046113 http://dx.doi.org/10.37349/etat.2021.00065

Ejemplares similares

Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma
por: Gaudio, Eugenio, et al.
Publicado: (2016)

Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma
por: Mensah, Afua A., et al.
Publicado: (2018)

BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance
por: Tarantelli, Chiara, et al.
Publicado: (2018)

Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma
por: Spriano, Filippo, et al.
Publicado: (2022)

The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax
por: Tarantelli, Chiara, et al.
Publicado: (2019)

Is There a Role for Dual PI3K/mTOR Inhibitors for Patients Affected with Lymphoma?
por: Tarantelli, Chiara, et al.
Publicado: (2020)

The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models
por: Hicks, Stuart W., et al.
Publicado: (2019)

United we stand: Double targeting of CD79B and CD20 in diffuse large B‐cell lymphoma
por: Tarantelli, Chiara, et al.
Publicado: (2022)

Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response
por: Mensah, Afua Adjeiwaa, et al.
Publicado: (2014)

m_b at M_Z
por: DELPHI Collaboration
Publicado: (2018)

$m_b$ at $M_Z$
por: Abreu, P, et al.
Publicado: (1997)

Exon–Intron Differential Analysis Reveals the Role of Competing Endogenous RNAs in Post-Transcriptional Regulation of Translation
por: Munz, Nicolas, et al.
Publicado: (2021)

Natural history of MZ B cells
por: Nemazee, David
Publicado: (2021)

Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors
por: Unzue, Andrea, et al.
Publicado: (2020)

Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models
por: Gaudio, Eugenio, et al.
Publicado: (2020)

Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type
por: Priebe, Valdemar, et al.
Publicado: (2020)

Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis
por: Arribas, Alberto J., et al.
Publicado: (2022)

Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
por: Chilà, Rosaria, et al.
Publicado: (2014)

Experimental determination of the $m_b(M_Z)$ in DELPHI
por: Marti i Gracia, S., et al.
Publicado: (1998)

Determination of the b quark at the Mz \scale with the DELPHI detector at LEP
por: Bambade, P, et al.
Publicado: (2005)

ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma
por: Sartori, Giulio, et al.
Publicado: (2021)

Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain
por: Ferguson, Fleur M., et al.
Publicado: (2013)

Determination of the b quark mass at the Mz scale with the DELPHI detector at LEP
por: Costa, Maria Jose
Publicado: (2003)

Determination of the b quark mass at the $M_Z$ scale with the DELPHI detector at LEP
por: Abdallah, J., et al.
Publicado: (2006)

Determination of the b quark mass at the $M_z$ scale with the DELPHI detector at LEP
por: Bambade, P, et al.
Publicado: (2003)

Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization
por: Cascione, Luciano, et al.
Publicado: (2019)

PI3Kδ Inhibitors as Immunomodulatory Agents for the Treatment of Lymphoma Patients
por: Tarantelli, Chiara, et al.
Publicado: (2021)

On the relevance of the dependence of the t, s-t correction on M_Z
por: Quast, G, et al.
Publicado: (1999)

DNA Copy Number Changes in Diffuse Large B Cell Lymphomas
por: Cascione, Luciano, et al.
Publicado: (2020)

Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors
por: Guidetti, Francesca, et al.
Publicado: (2023)

Do MZ twins have discordant experiences of friendship? A qualitative hypothesis-generating MZ twin differences study
por: Asbury, Kathryn, et al.
Publicado: (2017)

Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-escalation, phase I study
por: Stathis, Anastasios, et al.
Publicado: (2018)

IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
por: Johnson, Zoë, et al.
Publicado: (2023)

Correction: Do MZ twins have discordant experiences of friendship? A qualitative hypothesis-generating MZ twin differences study
por: Asbury, Kathryn, et al.
Publicado: (2017)

Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs
por: Girardini, Miriam, et al.
Publicado: (2019)

Draft Genome Sequences of Two Streptomyces Strains, MZ03-37(T) and MZ03-48, Isolated from Lava Tube Speleothems
por: Gonzalez-Pimentel, Jose L., et al.
Publicado: (2020)

Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences
por: Barreca, Marilia, et al.
Publicado: (2022)

Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia
por: Baragaño Raneros, Aroa, et al.
Publicado: (2021)

BET bromodomain proteins are required for glioblastoma cell proliferation
por: Pastori, Chiara, et al.
Publicado: (2014)

Determinacion de la constante de acoplamiento fuerte para quarks b, $\alpha^{b_s}$ (Mz), con el detector DELPHI en LEP
por: Valls Ferrer, Juan Antonio
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_ifl54acf6dmerepkk19ua9fr57